IRONWOOD PHARMACEUTICALS INC (IRWD)
Ironwood Pharmaceuticals, Inc. is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics segment. The company was founded on January 5, 1998 and is headquartered in Boston, MA.
Address
100 SUMMER STREET, SUITE 2300
BOSTON, MA 02110
Founded
1998
Number of Employees
267
Website
http://www.ironwoodpharma.com
Buyback
Buyback Data | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
---|---|---|---|---|---|---|---|---|---|---|---|---|
$ Amount Purchased ($ in 000s) |
- | - | - | - | - | - | - | $27,129 | $156,261 | - | - | $91,695 |
Average Price | - | - | - | - | - | - | - | $11.51 | $11.55 | - | - | $11.55 |
# Shares Purchased | - | - | - | - | - | - | - | 2,357,000 | 13,523,434 | - | - | 7,940,217 |
Buyback Performance | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Return to Date | - | - | - | - | - | - | - | -65.2% | -65.4% | - | - | -65.4% |
S&P 500 Return to Date | - | - | - | - | - | - | - | 31.7% | 37.3% | - | - | 34.5% |
Excess Total Return | - | - | - | - | - | - | - | -96.9% | -102.7% | - | - | -99.8% |
Quartile Rank |
|
|
|
|
|
|
|
|
|
|
|
|
Percentile Rank | - | - | - | - | - | - | - | 8% | 7% | - | - | 9% |
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)